Oncoceutics Competitors and Similar CompaniesClear all

Oncoceutics's competitors and similar companies include Vivoryon Therapeutics, Moleculin Biotech and Shanghai Junshi Biosciences.

	Oncoceutics Oncoceutics was a biotechnology company that developed small molecule compounds targeting G protein-coupled receptors for oncology applications.	Vivoryon Therapeutics Vivoryon Therapeutics (previously known as Probiodrug) is a precision intervention company specializing in discovering and developing therapies for patients suffering from age-related diseases.	Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.	Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
Founding Date	Founding Date 2009	Founding Date 1997	Founding Date 2006	Founding Date 2012
Type	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Philadelphia, US HQ	Locations Halle (Saale), DE HQ München, DE	Locations Houston, US HQ	Locations Shanghai, CN HQ
Employees	Employees 12	Employees 14	Employees 176% decrease	Employees 2,578
Valuation ($)	Valuation ($) N/A	Valuation ($) 69.8 m	Valuation ($) 7.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥2.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥466.5m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit €265k (FY, 2025)	Gross profit N/A	Gross profit ¥2b (FY, 2025)
Net income	Net income N/A	Net income (€8.9m) (FY, 2025)	Net income ($33.6m) (FY, 2025)	Net income (¥1b) (FY, 2025)

For sources of this data, please see the company profile

View Company Profiles

Vivoryon Therapeutics

Halle (Saale), DE

Employees

Vivoryon Therapeutics (previously known as Probiodrug) is a precision intervention company specializing in discovering and developing therapies for patients suffering from age-related diseases.

View company

Moleculin Biotech

Houston, US

Employees

17↓ 6% decrease

Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.

View company

Shanghai Junshi Biosciences

Shanghai, CN

Employees

2,578

Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.